Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined PET and MR Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 1: Simultaneous PET and 3T MRI

NCT05232955 is registered in ClinicalTrials.gov with Max Planck Institute for Human Cognitive and Brain Sciences as lead sponsor.

NCT NCT05232955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05232955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined PET and MR Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 1: Simultaneous PET and 3T MRI
Lead sponsor
Max Planck Institute for Human Cognitive and Brain Sciences
Phase
Observational
Overall status
Completed
Start date
May 4, 2022
Completion date
July 4, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gilles de la tourette syndrome, tourette syndrome